— Know what they know.
Not Investment Advice
Also trades as: VRNOF (OTC) · $vol 1M · VRNO.CN (CNQ) · $vol 0M

VRNO.NE NEO

Verano Holdings Corp.
1W: -11.7% 1M: -10.3% 3M: -15.4% YTD: +353.0% 1Y: +214.6% 3Y: +99.5% 5Y: -51.1%
C$7.49 ($5.25)
-0.13 (-1.71%)
 
Weekly Expected Move ±6.9%
C$6 C$7 C$8 C$8 C$9
NEO · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 47 · C$553.6M mcap · 66M float · 0.090% daily turnover

Income Trends

Revenue
$836M -4.9% ▼
5Y CAGR: +22.2%
Gross Profit
$429M -3.4% ▼
5Y CAGR: +22.2%
Operating Income
$95M +140.2% ▲
5Y CAGR: -5.1%
Net Income
-$262M +23.2% ▲
EPS (Diluted)
$-0.72 +26.5% ▲
EBITDA
$222M +335.1% ▲
5Y CAGR: +17.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$925M$1.1B$938M$879M$836M
YoY Growth+201.8%+23.8%-18.0%-6.4%-4.9%
Cost of Revenue$520M$610M$463M$435M$407M
Gross Profit$405M$535M$475M$444M$429M
Gross Margin43.8%46.7%50.6%50.5%51.3%
R&D Expenses$0$0$0$0$0
SG&A Expenses$330M$448M$332M$353M$333M
Operating Expenses$330M$448M$390M$681M$333M
Operating Income$75M$87M$85M-$237M$95M
Operating Margin8.1%7.6%9.0%-27.0%11.4%
Interest Expense$24M$49M$60M$55M$55M
Income Before Tax$61M-$213M$28M-$300M-$169M
Tax Expense$130M$137M$145M$42M$93M
Net Income-$72M-$350M-$117M-$342M-$262M
Net Margin-7.8%-30.6%-12.5%-38.9%-31.4%
EPS (Diluted)$-0.22$-1.03$-0.34$-0.98$-0.72
EBITDA$213M$47M$239M-$94M$222M
Shares Outstanding324M340M343M350M363M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms